Navigation Links
Oncothyreon's PX-866 is effective in preclinical model of pulmonary fibrosis
Date:5/18/2009

risks and uncertainties, including risks and uncertainties related to Oncothyreon's business and the general economic environment. Many of these risks and uncertainties are beyond Oncothyreon's control. These risks, uncertainties and other factors could cause our actual results to differ materially from those projected in forward-looking statements. Risks, uncertainties, and assumptions include those predicting the timing, duration and results of clinical trials, the timing and results of regulatory reviews, the safety and efficacy of PX-866, and the indications for which PX-866 might be developed. There can be no guarantee that the results of preclinical studies will be predictive of either safety or efficacy in future clinical trials. These and other risks and uncertainties are described in the reports and other documents filed by Oncothyreon Inc. with the SEC and/or Canadian regulatory authorities.

Although Oncothyreon believes that any forward-looking statements contained herein are reasonable, it can give no assurance that its expectations are correct. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. For a detailed description of the risks and uncertainties associated with Oncothyreon, you are encouraged to review the official corporate documents filed with the securities regulators in the United States on U.S. EDGAR and in Canada on SEDAR. Oncothyreon is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.


'/>"/>
SOURCE Oncothyreon Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Data for Oncothyreons PX-12 and PX-866 presented at AACR Annual Meeting
2. Oncothyreon files investigational new drug application for PX-866 oncology compound
3. Oncothyreon initiates Phase 1 trial of PX-866 cancer compound
4. Phase III Trial Finds Pharmaxis Bronchitol Effective
5. New nanoparticle vaccine is more effective but less expensive
6. American and European Parkinsons Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot
7. ProMed Alliance International Inc. Corporate Name and Trading Symbol Expected to Change Effective Tomorrow
8. InVitrias Animal Free Lacromin(TM) Provides a Cost-Effective Improvement Over Transferrin
9. MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition
10. Free White Paper Available for Clinical Laboratory Managers: Effectively Isolating Anaerobic Bacteria
11. DNA sensors found to be an effective artificial nose
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014 Reportlinker.com announces ... available in its catalogue: Global ... http://www.reportlinker.com/p02316661/Global-Biodegradable-Packaging-Materials-Market-2014-2018.html About ... that are readily decomposed by the action ... non-degradable packaging in terms of raw materials, ...
(Date:8/27/2014)... 27, 2014 Research and Markets ... Lactic Acid  (Biodegradable Polymer, Food & Beverage, Personal ... to 2019" report to their offering. ... with an asymmetrical carbon atom. The main applications ... food and beverage, personal care product, and pharmaceutical ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportbuyer.com ... The Graphene Opportunity - A Rational View ... Graphene The New Nanotech? A similar amount ... of applications ranging from microelectronics to water treatment, ... announced the availability of the Graphene Opportunity Report, ...
(Date:8/27/2014)... JUNCTION, N.J. , Aug. 27, 2014 ... innovative drug delivery technologies, today announced that it has ... Jersey Business & Industry Association,s 2014 Awards for ... were selected by an independent panel of judges from ... company volunteers. Award winners will be honored at a ...
Breaking Biology Technology:Global Biodegradable Packaging Materials Market 2014-2018 2Global Biodegradable Packaging Materials Market 2014-2018 3Global Biodegradable Packaging Materials Market 2014-2018 4Global Biodegradable Packaging Materials Market 2014-2018 5Global Biodegradable Packaging Materials Market 2014-2018 6Global Biodegradable Packaging Materials Market 2014-2018 7Global Lactic Acid (Biodegradable Polymer, Food & Beverage, Personal Care & Pharmaceutical) Market - Trends & Forecasts to 2019 2The Graphene Opportunity - A Rational View 2The Graphene Opportunity - A Rational View 3The Graphene Opportunity - A Rational View 4Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2
... step closer to creating a micro-aircraft that flies with the ... aerodynamic secrets of insect flight. Dr John Young, from ... and a team of animal flight researchers from Oxford University,s ... locusts in action in a wind tunnel, capturing how the ...
... , , SAN ... ("STI"), a privately-held and development-stage biopharmaceutical company with a ... human therapeutic antibodies for the treatment of a variety ... of QuikByte Software, Inc. (OTC Bulletin Board: QBSW), a ...
... , , , , ... independent, nonprofit research and development institute, announced today that John J. ... September 1, 2009. Young will become the SRI Board,s tenth ... the business community. , , "Throughout his career, ...
Cached Biology Technology:Secrets of insect flight revealed 2Sorrento Therapeutics, Inc. and QuikByte Software, Inc. Complete Merger 2Sorrento Therapeutics, Inc. and QuikByte Software, Inc. Complete Merger 3Sorrento Therapeutics, Inc. and QuikByte Software, Inc. Complete Merger 4John J. Young, Jr. Joins SRI Board of Directors 2John J. Young, Jr. Joins SRI Board of Directors 3
(Date:8/27/2014)... the Volunteer Wildfire Services of South Africa as "Cape ... residents in certain parts of the province on Monday ... high veld fire danger rating is expected in the ... Kei and Mnquma area. Strong winds often occurred ... bring lightning strikes and subsequent fire and the wind ...
(Date:8/27/2014)... number of consumers are willing to pay a premium ... whether they,re getting what the label claims is another ... devising a new way to make sure farms are ... ACS, Journal of Agricultural and Food Chemistry , ... the Bavarian Health and Food Safety Authority and the ...
(Date:8/27/2014)... of studies have shown that excessive iron ... Parkinson,s disease. Previous studies from Chunyan Guo ... China have shown that baicalin prevented iron ... metal transporter 1 expression, and increased ferroportin ... rotenone-induced Parkinson,s disease rats. However, the relationship ...
Breaking Biology News(10 mins):
... night blindness, an inherited condition that affects one,s ability to ... mutation in a calcium channel protein that shuttles calcium into ... University School of Medicine have teased apart the molecular mechanism ... cells control calcium levels. The discovery, published in the Feb. ...
... a serious toll on plants and animals alike. When cells ... and, without water as a medium, chemicals and enzymes inside ... named "resurrection fern" ( Polypodium polypodioides ), can survive extreme ... their water content. How do the cells in these desiccation-tolerant ...
... March 18, 2010. How did China and Australia develop ... Europe? A panel of U.S. experts will try to ... a workshop at the National Science Foundation (NSF) in Arlington, ... the National Science Foundation and other Federal agencies, the World ...
Cached Biology News:Understanding night blindness and calcium 2Bringing dehydrated plants 'back to life' 2Bringing dehydrated plants 'back to life' 3Workshop on R&D for rapid vaccine development and production in Asia/Australia 2
... This goat anti-rabbit IgG FITC ... antibody' for immunofluorescent staining on tissues ... antibody is generated in rabbits. It ... controls, such as omitting the primary ...
1000X solution used for inducing CopyControl™ based vectors to high copy numbers...
Request Info...
HAS1 (C-14)...
Biology Products: